• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

传统与新型肥胖测量指标在代谢相关脂肪性肝病筛查中的比较。

Comparison between traditional and new obesity measurement index for screening metabolic associated fatty liver disease.

机构信息

Department of International Physical Examination and Health Center, Second Affiliated Hospital of Harbin Medical University, Harbin, China.

Department of Hygiene Microbiology, School of Public Health, Harbin Medical University, Harbin, China.

出版信息

Front Endocrinol (Lausanne). 2023 Apr 21;14:1163682. doi: 10.3389/fendo.2023.1163682. eCollection 2023.

DOI:10.3389/fendo.2023.1163682
PMID:37152940
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10160459/
Abstract

OBJECTIVES

Obesity measurement indexes have certain screening value for metabolic diseases. To investigate associations between metabolic associated fatty liver disease (MAFLD) and obesity measurement indexes, including traditional indexes (BMI, WC, WHtR) and new indexes (ABSI, BRI, VAI, LAP), and assess their screening ability.

METHODS

12,658 subjects aged 18-75 at the Health Center of a Class III Grade A Hospital were included, who were divided into MAFLD and non-MAFLD groups. Spearman's rank correlation was used to study the correlation between MAFLD and obesity measurement indexes. Receiver operating characteristic (ROC) curves were used to calculate the area under the curve (AUC) to evaluate their screening accuracy.

RESULTS

MAFLD had strong correlation with traditional BMI and new index LAP. ROC analysis showed that BMI had the highest AUC (0.89), followed by LAP (0.87). Stratification by BMI, LAP had the highest AUC (0.90) for MAFLD in population without obesity (BMI< 23kg/m), and its optimal cutoff value was 20.75, with a sensitivity and specificity of 85.9% and 79.0%, respectively.

CONCLUSIONS

We proposed a two-step screening strategy for MAFLD, combining BMI and LAP, and defined a high-risk population for MAFLD as follows: 1) BMI ≥ 23 kg/m; and 2) BMI< 23 kg/m and LAP ≥ 20.75.

摘要

目的

肥胖测量指标对代谢性疾病具有一定的筛查价值。本研究旨在探讨代谢相关脂肪性肝病(MAFLD)与肥胖测量指标(包括传统指标 BMI、WC、WHtR 和新指标 ABSI、BRI、VAI、LAP)之间的关系,并评估其筛查能力。

方法

本研究纳入了一家三级甲等医院健康中心 18-75 岁的 12658 名受试者,将其分为 MAFLD 组和非 MAFLD 组。采用 Spearman 秩相关分析 MAFLD 与肥胖测量指标的相关性。采用受试者工作特征(ROC)曲线计算曲线下面积(AUC)以评估其筛查准确性。

结果

MAFLD 与传统 BMI 和新指标 LAP 具有较强的相关性。ROC 分析显示,BMI 的 AUC 最高(0.89),其次是 LAP(0.87)。在 BMI<23kg/m²的非肥胖人群中,BMI 和 LAP 分层后,LAP 对 MAFLD 的 AUC 最高(0.90),其最佳截断值为 20.75,灵敏度和特异度分别为 85.9%和 79.0%。

结论

本研究提出了一种 MAFLD 的两步筛查策略,结合 BMI 和 LAP,将 MAFLD 的高危人群定义为:1)BMI≥23kg/m²;2)BMI<23kg/m²且 LAP≥20.75。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/319b/10160459/5d8a125c6a40/fendo-14-1163682-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/319b/10160459/0dfe8473d9b0/fendo-14-1163682-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/319b/10160459/1827cf73d468/fendo-14-1163682-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/319b/10160459/a4a198dce4c1/fendo-14-1163682-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/319b/10160459/e75fd0523f71/fendo-14-1163682-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/319b/10160459/5d8a125c6a40/fendo-14-1163682-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/319b/10160459/0dfe8473d9b0/fendo-14-1163682-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/319b/10160459/1827cf73d468/fendo-14-1163682-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/319b/10160459/a4a198dce4c1/fendo-14-1163682-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/319b/10160459/e75fd0523f71/fendo-14-1163682-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/319b/10160459/5d8a125c6a40/fendo-14-1163682-g005.jpg

相似文献

1
Comparison between traditional and new obesity measurement index for screening metabolic associated fatty liver disease.传统与新型肥胖测量指标在代谢相关脂肪性肝病筛查中的比较。
Front Endocrinol (Lausanne). 2023 Apr 21;14:1163682. doi: 10.3389/fendo.2023.1163682. eCollection 2023.
2
Comparison of visceral, general and central obesity indices in the prediction of metabolic syndrome in maintenance hemodialysis patients.比较维持性血液透析患者内脏型肥胖、全身型肥胖和中心型肥胖指数对代谢综合征的预测价值。
Eat Weight Disord. 2020 Jun;25(3):727-734. doi: 10.1007/s40519-019-00678-9. Epub 2019 Apr 9.
3
The lipid accumulation product is a powerful tool to diagnose metabolic dysfunction-associated fatty liver disease in the United States adults.脂滴蓄积产物是诊断美国成年人代谢功能障碍相关脂肪性肝病的有力工具。
Front Endocrinol (Lausanne). 2022 Nov 4;13:977625. doi: 10.3389/fendo.2022.977625. eCollection 2022.
4
Waist-to-height ratio, an optimal anthropometric indicator for metabolic dysfunction associated fatty liver disease in the Western Chinese male population.腰围身高比是西方中国男性人群代谢相关脂肪性肝病的最佳人体测量指标。
Lipids Health Dis. 2021 Oct 27;20(1):145. doi: 10.1186/s12944-021-01568-9.
5
Prediction of MAFLD and NAFLD using different screening indexes: A cross-sectional study in U.S. adults.使用不同的筛查指标预测 MAFLD 和 NAFLD:美国成年人的横断面研究。
Front Endocrinol (Lausanne). 2023 Jan 19;14:1083032. doi: 10.3389/fendo.2023.1083032. eCollection 2023.
6
Predicting value of five anthropometric measures in metabolic syndrome among Jiangsu Province, China.预测中国江苏省五种人体测量指标在代谢综合征中的价值。
BMC Public Health. 2020 Aug 31;20(1):1317. doi: 10.1186/s12889-020-09423-9.
7
Comparison of novel visceral obesity indexes with traditional obesity measurements in predicting of metabolically unhealthy nonobese phenotype in hemodialysis patients.比较新型内脏肥胖指标与传统肥胖测量指标在预测血液透析患者代谢不健康非肥胖表型中的作用。
BMC Endocr Disord. 2021 Dec 19;21(1):244. doi: 10.1186/s12902-021-00907-2.
8
The value of combining the simple anthropometric obesity parameters, Body Mass Index (BMI) and a Body Shape Index (ABSI), to assess the risk of non-alcoholic fatty liver disease.联合简单人体测量肥胖参数,即体重指数(BMI)和体脂指数(ABSI),评估非酒精性脂肪性肝病风险的价值。
Lipids Health Dis. 2022 Oct 20;21(1):104. doi: 10.1186/s12944-022-01717-8.
9
Validation of non-invasive indicators in the screening of metabolic dysfunction-associated fatty liver disease: a cross-sectional study among Uighurs in rural Xinjiang.代谢相关脂肪性肝病无创指标筛查的验证:新疆农村维吾尔族人群的横断面研究。
Eur J Med Res. 2023 Dec 2;28(1):555. doi: 10.1186/s40001-023-01536-2.
10
Cardiometabolic index: A new predictor for metabolic associated fatty liver disease in Chinese adults.代谢相关脂肪性肝病的新预测因子:中国人的心脏代谢指数。
Front Endocrinol (Lausanne). 2022 Sep 16;13:1004855. doi: 10.3389/fendo.2022.1004855. eCollection 2022.

引用本文的文献

1
A significant atypical U-shaped relationship exists between Lipid Accumulation Product and depression prevalence among Chinese middle-aged and elderly men: a cross-sectional study based on CHARLS.在中国中老年男性中,脂质蓄积产物与抑郁症患病率之间存在显著的非典型U型关系:一项基于中国健康与养老追踪调查(CHARLS)的横断面研究
Front Nutr. 2025 May 21;12:1561990. doi: 10.3389/fnut.2025.1561990. eCollection 2025.
2
Effectiveness of body roundness index for the prediction of nonalcoholic fatty liver disease: a systematic review and meta-analysis.身体圆润度指数预测非酒精性脂肪性肝病的有效性:一项系统评价和荟萃分析
Lipids Health Dis. 2025 Mar 27;24(1):117. doi: 10.1186/s12944-025-02544-3.
3

本文引用的文献

1
Screening for MAFLD: who, when and how?非酒精性脂肪性肝病(MAFLD)的筛查:对象、时机与方法?
Ther Adv Endocrinol Metab. 2023 Jan 21;14:20420188221145650. doi: 10.1177/20420188221145650. eCollection 2023.
2
Lipid Accumulation Product Better Predicts Metabolic Status in Lean Polycystic Ovary Syndrome than that by Visceral Adiposity Index.与内脏脂肪指数相比,脂质积聚产物能更好地预测瘦型多囊卵巢综合征的代谢状况。
J Hum Reprod Sci. 2022 Jan-Mar;15(1):27-33. doi: 10.4103/jhrs.jhrs_114_21. Epub 2022 Mar 31.
3
A body shape index could serve to identify individuals with metabolic syndrome and increased arterial stiffness in the middle-aged population.
Obesity-related indices are associated with self-reported infertility in women: findings from the National Health and Nutrition Examination Survey.
肥胖相关指标与女性自我报告的不孕症有关:来自美国国家健康与营养检查调查的结果。
J Int Med Res. 2025 Feb;53(2):3000605251315019. doi: 10.1177/03000605251315019.
4
Lipid accumulation product and gallstone risk in US adults: A cross-sectional analysis of NHANES 2017-2020 data.美国成年人的脂质积聚产物与胆结石风险:对2017 - 2020年美国国家健康与营养检查调查(NHANES)数据的横断面分析
PLoS One. 2024 Dec 5;19(12):e0315235. doi: 10.1371/journal.pone.0315235. eCollection 2024.
5
The Different Predictive Effects of Multiple Body Fat Indexes on Metabolic Dysfunction-Associated Fatty Liver Disease.多种体脂指数对代谢功能障碍相关脂肪性肝病的不同预测作用。
Diabetes Metab Syndr Obes. 2024 Oct 19;17:3875-3890. doi: 10.2147/DMSO.S469859. eCollection 2024.
6
The association between body roundness index and osteoporosis in American adults: analysis from NHANES dataset.美国成年人身体圆润度指数与骨质疏松症之间的关联:来自美国国家健康与营养检查调查(NHANES)数据集的分析
Front Nutr. 2024 Oct 4;11:1461540. doi: 10.3389/fnut.2024.1461540. eCollection 2024.
7
Associations between metabolic dysfunction-associated fatty liver disease, chronic kidney disease, and abdominal obesity: a national retrospective cohort study.代谢功能障碍相关脂肪性肝病、慢性肾脏病与腹型肥胖之间的关联:一项全国性回顾性队列研究。
Sci Rep. 2024 Jun 2;14(1):12645. doi: 10.1038/s41598-024-63386-0.
8
Abdominal obesity as assessed by anthropometric measures associates with urinary incontinence in females: findings from the National Health and Nutrition Examination Survey 2005-2018.采用人体测量学指标评估的腹型肥胖与女性尿失禁相关:来自 2005-2018 年全国健康和营养调查的结果。
BMC Womens Health. 2024 Apr 2;24(1):212. doi: 10.1186/s12905-024-03059-2.
9
Machine learning identification of risk factors for heart failure in patients with diabetes mellitus with metabolic dysfunction associated steatotic liver disease (MASLD): the Silesia Diabetes-Heart Project.机器学习识别代谢相关脂肪性肝病(MASLD)合并糖代谢异常的糖尿病患者心力衰竭的危险因素:西里西亚糖尿病-心脏研究。
Cardiovasc Diabetol. 2023 Nov 20;22(1):318. doi: 10.1186/s12933-023-02014-z.
10
Diagnostic value of triglyceride-glucose index and related parameters in metabolism-associated fatty liver disease in a Chinese population: a cross-sectional study.中国人代谢相关脂肪性肝病中甘油三酯-葡萄糖指数及相关参数的诊断价值:一项横断面研究。
BMJ Open. 2023 Sep 29;13(9):e075413. doi: 10.1136/bmjopen-2023-075413.
体脂指数可用于识别中年人群中患有代谢综合征和动脉僵硬程度增加的个体。
Clin Nutr ESPEN. 2021 Dec;46:251-258. doi: 10.1016/j.clnesp.2021.10.001. Epub 2021 Oct 8.
4
Visceral Adiposity Index and Lipid Accumulation Product as diagnostic markers of Metabolic Syndrome in South Indians with Polycystic Ovary Syndrome.内脏脂肪指数和脂质蓄积产物作为南印度多囊卵巢综合征患者代谢综合征的诊断标志物。
J Hum Reprod Sci. 2021 Jul-Sep;14(3):234-243. doi: 10.4103/jhrs.jhrs_12_21. Epub 2021 Aug 25.
5
The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease.肥胖和脂质相关指标对预测非酒精性脂肪性肝病的存在的有用性。
Lipids Health Dis. 2021 Oct 10;20(1):134. doi: 10.1186/s12944-021-01561-2.
6
Comparison of obesity-related indices for identifying nonalcoholic fatty liver disease: a population-based cross-sectional study in China.比较肥胖相关指标在识别非酒精性脂肪性肝病中的作用:一项中国基于人群的横断面研究。
Lipids Health Dis. 2021 Oct 10;20(1):132. doi: 10.1186/s12944-021-01560-3.
7
The Improved Lipid Accumulation Product is an Accurate Index for Predicting Metabolic Syndrome in the Xinjiang Population.改良脂质蓄积产物是预测新疆人群代谢综合征的准确指标。
Biomed Environ Sci. 2021 Jun 20;34(6):503-507. doi: 10.3967/bes2021.070.
8
Visceral Adiposity Index, Triglyceride/High-Density Lipoprotein Ratio, and Lipid Accumulation Product Index to Discriminate Metabolic Syndrome Among Adult Type 1 Diabetes Patients.内脏脂肪指数、甘油三酯/高密度脂蛋白比值和脂质蓄积产物指数在成年 1 型糖尿病患者代谢综合征中的鉴别诊断作用。
Metab Syndr Relat Disord. 2021 Nov;19(9):507-512. doi: 10.1089/met.2021.0047. Epub 2021 Jul 20.
9
Non-alcoholic fatty liver disease.非酒精性脂肪性肝病。
Lancet. 2021 Jun 5;397(10290):2212-2224. doi: 10.1016/S0140-6736(20)32511-3. Epub 2021 Apr 21.
10
Nonalcoholic fatty liver disease in lean subjects: Prognosis, outcomes and management.非酒精性脂肪性肝病在瘦人群体中的:预后、结局和管理。
World J Gastroenterol. 2020 Nov 14;26(42):6514-6528. doi: 10.3748/wjg.v26.i42.6514.